Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Recruiting now

Conditions studied: Peripheral Vascular Diseases

In brief

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.

Key facts

Study ID

NCT04674969

Run by

Boston Scientific Corporation

People needed

5000

Starts

2021-03-29

Expected to finish

2028-01-01

Last updated by the study team

2026-07-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18 years and older
• Written informed consent (patient data release-form)
• Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide

You may not qualify if…

• Life expectancy of <1 year

Where it is running

• Memorial Sloan Kettering Hospital — New York, New York, United States (enrolling)
• Weill Cornell Medicine/New York-Presbyterian Hospital — New York, New York, United States (enrolling)
• Buffalo General Hospital — Buffalo, New York, United States (enrolling)
• Mount Sinai — New York, New York, United States (enrolling)
• Cedars - Sinai Medical Center — Los Angeles, California, United States (enrolling)
• Yale University School of Medicine — New Haven, Connecticut, United States (enrolling)
• PIH Health Good Samaritan Hospital — Los Angeles, California, United States (enrolling)
• Newark Beth Israel Medical Center — Newark, New Jersey, United States (enrolling)
• New York University Medical Center — New York, New York, United States (enrolling)
• Columbia University — New York, New York, United States (enrolling)
• Adventist Health St Helena Hospital — St. Helena, California, United States (enrolling)
• South Georgia Medical Center — Valdosta, Georgia, United States (enrolling)
• Rush University — Chicago, Illinois, United States (enrolling)
• St. John's Hospital/ Prairie Education and Research Cooperative — Springfield, Illinois, United States (enrolling)
• Christiana Hospital — Newport, Delaware, United States (enrolling)
• Ascension St. Vincent's Hospital — Indianapolis, Indiana, United States (enrolling)
• Washington Hospital Center — Washington D.C., District of Columbia, United States (enrolling)
• Ochsner Clinic Foundation — Kenner, Louisiana, United States (enrolling)
• St. Bernard's Medical Center — Jonesboro, Arkansas, United States (enrolling)
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)
• Tallahassee Memorial Hospital — Tallahassee, Florida, United States (enrolling)
• North Mississippi Medical Center — Tupelo, Mississippi, United States (enrolling)
• Emory University Hospital — Atlanta, Georgia, United States (enrolling)
• Hackensack University Medical Center — Hackensack, New Jersey, United States (enrolling)
• Duke University Medical Center — Durham, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.